OFFICIAL JOURNAL OF THE CONTROLLED RELEASE SOCIETYAND THE JAPANESE SOCIETY OF DRUG DELIVERY SYSTEM

VOLUME 221, 10 JANUARY 2016 ISSN: 0168-3659

COVER STORYAn integrated assessment of PEGylated liposomal doxorubicin products

Vol. 221 JOURNAL OF CONTROLLED RELEASE 10 JANUARY 2016

CONTENTS

Cited in: BIOSIS/Biological Abstracts; CAB Abstracts; Chemical Abstracts Services; Current Contents (Life Sciences); EMBASE/Excerpta Medica; International Pharmaceutical Abstracts; PUBMED/MEDLINE/Index Medicus; Polymer Contents; Science Citation Index. Also covered in the abstract and citation database Scopus®. Full text available in ScienceDirect ®

Available online at www.sciencedirect.com

05054

Cover Story An integrated assessment of PEGylated liposomal doxorubicin products

K. Park (West Lafayette, USA) 71

Review What's Next for Gastrointestinal Disorders: No Needles?

A.M. Urbanska , E.D. Karagiannis , A.S. Au , S.Y. Dai , M. Mozafari and S. Prakash ( Montreal, Canada; Cambridge, New York, USA; Tehran, Iran ) 48

Research papers An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products

Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome P.P. Wibroe , D. Ahmadvand , M.A. Oghabian , A. Yaghmur and S.M. Moghimi ( Copenhagen Ø, Denmark; Tehran, Iran ) 1

Gold nanoparticles modified with self-assembled hybrid monolayer of triblock aptamers as a photoreversible anticoagulant S.-S. Huang , S.-C. Wei , H.-T. Chang , H.-J. Lin and C.-C. Huang ( Keelung, Taipei, Kaohsiung, Taiwan ) 9

pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery M.C. Koetting , J.F. Guido , M. Gupta , A. Zhang and N.A. Peppas ( Austin, USA ) 18

Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition Y. Jiang , N. Yang , H. Zhang , B. Sun , C. Hou , C. Ji , J. Zheng , Y. Liu and P. Zuo ( Beijing, China ) 26

Polymeric micellar nanoplatforms for Fenton reaction as a new class of antibacterial agents S.-C. Park , N.-H. Kim , W. Yang , J.-W. Nah , M.-K. Jang and D. Lee ( Suncheon, Chonbuk, Jeonju, Republic of Korea) 37

Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis T.-T. Lin , D.-Y. Gao , Y.-C. Liu , Y.-C. Sung , D. Wan , J.-Y. Liu , T. Chiang , L. Wang and Y. Chen ( Hsinchu, Taiwan ) 62

Graphical Abstracts Contents Listing $doi: 10.1016/S0168-3659(15)00801-9 e1

Calendar I

Additional material available online.

3

EL

SEV

IER

JOU

RN

AL O

F C

ON

TR

OLLE

D R

ELE

AS

E

VO

L. 221 (2016) P. 1–

72

221